tirzepatide clinical trials Who Is Right For? A Guide to Patient Selection TRIUMPH 5: Retatrutide vs Tirzepatide

Understanding the trade-offs between each dose tier helps patients and providers make informed decisions about escalation or maintenance

Chronic hyperprolactinemia induces hyperinsulinemia, eventually resulting in beta cells exhaustion and T2DM (Figure 2)

Growth hormone side effects are typically dose related and may include redness at injection site, hyperglycemia, headache, flushing, joint pain, hyperactivity and in even rare cases a rash

The ERK pathway is essential for the activation of CREB and subsequent BDNF transcription

Timelines vary by country and by how questions are coordinated across national competent authorities and ethics committees